DXCM News and Press, DexCom Inc. From 09/15/23

2023-09-15 18:11:16 ET A notable price target cut from an analyst was followed by a dip in the price of DexCom (NASDAQ: DXCM) stock on Friday. Investors traded out of the specialty medical device maker, reducing its value by more than 5%. That was a far steeper decline than the 1.2%...

2023-09-14 16:28:35 ET More on DexCom, Tandem Diabetes, Insulet Why DexCom May Be Up To 40% Undervalued Tandem Diabetes: Cash Flow And Profitability Trends A Drag On Equity Performance, Reiterate Hold Insulet: Losing More Weight Dexcom Denies Weight Loss Drug...

2023-09-12 08:00:00 ET Summary DexCom is a leading healthcare stock that has seen significant growth, with shares returning close to 1,400% in the past decade. DXCM stock has faced resistance and is currently 37% below its all-time high, partly due to competition from weight loss ...

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced the availability of its Dexcom ONE real-time CGM sensor via reimbursement, in France. Dexcom’s announcement brings the company’s highly researched ...

2023-09-07 13:38:45 ET More on Medtronic, Insulet, etc. Compare metrics for MDT to PODD, TNDM Medtronic plc ( MDT ) Wells Fargo 2023 Healthcare Conference (Transcript) Medtronic: The Crossroads Of Its Growth Trajectory Tandem Diabetes: Cash Flow And Profi...

2023-09-07 11:41:22 ET Summary DexCom is a major player in the continuous glucose monitoring space, with steadily growing revenues and a breakout year in 2020. DXCM's market cap valuation has reached $40 billion, leading to high expectations for future growth. Dexcom faces new...

2023-09-06 13:47:07 ET More on Abbott, DexCom, etc. Compare metrics for ABT to DXCM, MDT, SENS Medtronic: The Crossroads Of Its Growth Trajectory Medtronic: The Tide Is Turning Medtronic: Dark Clouds Are Clearing - Outperformance Ahead Senseonics Face...

2023-09-01 07:50:37 ET More on DexCom DexCom: I Expect Growth To Continue At This Strong Rate, Buy DexCom: Fantastic Growth But A High Premium To Pay Right Now DexCom boosts 2023 revenue guidance on Q2 results Dividend for DexCom For further details s...

The world’s most connected continuous glucose monitoring system, † Dexcom G6, is now the first and only CGM to connect with the Omnipod 5 Automated Insulin Delivery (AID) System in Germany. DexCom, Inc. (Nasdaq: DXCM), global manufacturer of systems for real-time c...

2023-08-29 13:29:41 ET More on IHI IHI: Too Expensive Considering Long-Term Rate Uncertainty Johnson & Johnson’s MedTech performance rallies industry Life science tools industry drags healthcare in S&P 500 MedTech, hospital stocks slump after T...